| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.06e-09 | 20 | 135 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.41e-07 | 36 | 135 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RGPD4 RGPD2 RANBP2 RGPD8 TRIML2 LONRF1 TRIM39 TTC3 TGM2 UBR5 LMO7 ZNF451 RGPD3 MED23 | 1.53e-05 | 532 | 135 | 14 | GO:0016755 |
| GeneOntologyMolecularFunction | acyltransferase activity | RGPD4 RGPD2 RANBP2 RGPD8 TRIML2 LONRF1 TRIM39 TTC3 SIRT1 ESCO2 TGM2 ACSM4 UBR5 LMO7 ZNF451 RGPD3 MED23 | 1.92e-05 | 775 | 135 | 17 | GO:0016746 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.18e-05 | 50 | 135 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.90e-05 | 53 | 135 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RGPD4 RGPD2 RANBP2 RGPD8 TRIML2 LONRF1 TRIM39 TTC3 UBR5 LMO7 ZNF451 RGPD3 MED23 | 4.51e-05 | 512 | 135 | 13 | GO:0019787 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RGPD4 RGPD2 RANBP2 RGPD8 TRIML2 LONRF1 TRIM39 UBR5 ZNF451 RGPD3 MED23 | 8.44e-05 | 398 | 135 | 11 | GO:0061659 |
| GeneOntologyMolecularFunction | IkappaB kinase activity | 1.36e-04 | 3 | 135 | 2 | GO:0008384 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 RGPD2 RANBP2 RGPD8 IARS1 PIH1D2 EXOC5 XPO5 RGPD3 DIAPH3 | 1.72e-04 | 360 | 135 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | 3.41e-04 | 321 | 135 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.23e-04 | 93 | 135 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.30e-04 | 279 | 135 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 IQSEC3 EPS8L2 RGPD8 SWAP70 ARHGAP35 RGPD3 TBCD RGPD5 | 6.70e-04 | 507 | 135 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 IQSEC3 EPS8L2 RGPD8 SWAP70 ARHGAP35 RGPD3 TBCD RGPD5 | 6.70e-04 | 507 | 135 | 11 | GO:0030695 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.18e-09 | 9 | 131 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.11e-09 | 20 | 131 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.35e-09 | 10 | 131 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.18e-08 | 13 | 131 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.83e-08 | 14 | 131 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | RGPD4 RGPD2 RANBP2 RGPD8 SPG11 UBR5 RGPD3 TNFRSF1A HSPA8 RGPD5 | 4.85e-07 | 195 | 131 | 10 | GO:0006606 |
| GeneOntologyBiologicalProcess | import into nucleus | RGPD4 RGPD2 RANBP2 RGPD8 SPG11 UBR5 RGPD3 TNFRSF1A HSPA8 RGPD5 | 6.40e-07 | 201 | 131 | 10 | GO:0051170 |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RGPD2 RANBP2 RGPD8 ANP32B SPG11 UPF2 UBR5 XPO5 RGPD3 TNFRSF1A HSPA8 RGPD5 | 8.85e-07 | 378 | 131 | 13 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RGPD2 RANBP2 RGPD8 ANP32B SPG11 UPF2 UBR5 XPO5 RGPD3 TNFRSF1A HSPA8 RGPD5 | 8.85e-07 | 378 | 131 | 13 | GO:0006913 |
| GeneOntologyBiologicalProcess | RNA transport | 1.81e-06 | 175 | 131 | 9 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.81e-06 | 175 | 131 | 9 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.08e-06 | 178 | 131 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 RGPD2 RANBP2 RGPD8 WRN SPG11 SIRT1 UBR5 RGPD3 TNFRSF1A HSPA8 RGPD5 | 3.47e-06 | 362 | 131 | 12 | GO:0034504 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 4.06e-06 | 38 | 131 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 5.97e-06 | 71 | 131 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.04e-05 | 217 | 131 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | cell cycle process | ANKRD31 SYCP2L DCDC1 ANP32B WRN CKAP5 TRIM39 SMC5 SIRT1 CCND2 ESCO2 EXOC5 WIZ CCNB3 CDC16 PRKCE PSME3 PRKDC TAF2 DIAPH3 RPA4 HSPA8 DNM2 KIF2C | 1.18e-05 | 1441 | 131 | 24 | GO:0022402 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cytoskeleton polarity | 2.05e-05 | 9 | 131 | 3 | GO:0030952 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 2.36e-05 | 54 | 131 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.43e-05 | 185 | 131 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 3.10e-05 | 249 | 131 | 9 | GO:0015931 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 7.68e-05 | 111 | 131 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor-mediated signaling pathway | 8.91e-05 | 71 | 131 | 5 | GO:0010803 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 9.35e-05 | 115 | 131 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | DCDC1 ANP32B CKAP5 TRIM39 SMC5 SIRT1 CCND2 EXOC5 CCNB3 CDC16 PSME3 PRKDC TAF2 HSPA8 DNM2 KIF2C | 1.05e-04 | 854 | 131 | 16 | GO:1903047 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 1.16e-04 | 231 | 131 | 8 | GO:0006109 | |
| GeneOntologyBiologicalProcess | response to cholecystokinin | 1.20e-04 | 3 | 131 | 2 | GO:0061847 | |
| GeneOntologyBiologicalProcess | cellular response to tumor necrosis factor | 1.23e-04 | 233 | 131 | 8 | GO:0071356 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.24e-04 | 121 | 131 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor-mediated signaling pathway | 1.61e-04 | 127 | 131 | 6 | GO:0033209 | |
| GeneOntologyBiologicalProcess | protein folding | 1.79e-04 | 246 | 131 | 8 | GO:0006457 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | ANP32B TRIM39 SMC5 CCND2 CCNB3 CDC16 PSME3 PRKDC TAF2 DIAPH3 RPA4 HSPA8 DNM2 | 1.82e-04 | 627 | 131 | 13 | GO:0044770 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.99e-04 | 132 | 131 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.16e-04 | 134 | 131 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | DCDC1 ANP32B CKAP5 TRIM39 SMC5 SIRT1 CCND2 EXOC5 CCNB3 CDC16 PSME3 PRKDC TAF2 HSPA8 TBCD DNM2 KIF2C | 2.38e-04 | 1014 | 131 | 17 | GO:0000278 |
| GeneOntologyBiologicalProcess | non-canonical inflammasome complex assembly | 2.38e-04 | 4 | 131 | 2 | GO:0160075 | |
| GeneOntologyBiologicalProcess | response to tumor necrosis factor | 2.47e-04 | 258 | 131 | 8 | GO:0034612 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 RGPD2 RANBP2 RGPD8 COPA ANP32B SPG11 ICE1 UBR5 XPO5 RGPD3 TNFRSF1A HSPA8 RGPD5 | 2.63e-04 | 740 | 131 | 14 | GO:0006886 |
| GeneOntologyBiologicalProcess | ectopic germ cell programmed cell death | 3.06e-04 | 21 | 131 | 3 | GO:0035234 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ANKRD31 DCDC1 ANP32B TRIM39 SMC5 SIRT1 CCND2 WIZ CDC16 PRKCE PSME3 PRKDC DIAPH3 RPA4 KIF2C | 3.11e-04 | 845 | 131 | 15 | GO:0010564 |
| GeneOntologyBiologicalProcess | mRNA transport | 3.31e-04 | 145 | 131 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CKAP5 SPG11 RFX3 SIRT1 FSIP2 ROPN1L KATNBL1 DNAAF10 TTLL11 SYNE2 DNAAF6 DIAPH3 HYDIN HSPA8 TBCD DNM2 KIF2C | 3.89e-04 | 1058 | 131 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-18-mediated signaling pathway | 3.95e-04 | 5 | 131 | 2 | GO:2000494 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of microtubule cytoskeleton polarity | 3.95e-04 | 5 | 131 | 2 | GO:0030951 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | ANP32B TRIM39 SMC5 CCND2 CCNB3 CDC16 PSME3 PRKDC TAF2 HSPA8 DNM2 | 4.10e-04 | 509 | 131 | 11 | GO:0044772 |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | RGPD4 RGPD2 RANBP2 RGPD8 SLC7A7 SIRT1 ACSL4 RGPD3 PRKCE NR1H4 | 4.60e-04 | 434 | 131 | 10 | GO:0062012 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 RGPD2 RANBP2 RGPD8 SMC5 SIRT1 CHUK LONP1 ZNF451 TTLL11 RGPD3 PRKCE PRKDC TNFRSF1A IKBKB BANK1 | 4.69e-04 | 976 | 131 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | cilium assembly | ARL13A ARHGAP35 RFX3 FSIP2 EXOC5 DNAAF10 SYNE2 DNAAF6 HYDIN DNM2 | 5.49e-04 | 444 | 131 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 RGPD2 RANBP2 RGPD8 ARL13A WRN SPG11 SMC5 SIRT1 ESCO2 FSIP2 UBR5 RGPD3 TNFRSF1A HSPA8 KIF2C RGPD5 | 5.51e-04 | 1091 | 131 | 17 | GO:0033365 |
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 5.90e-04 | 294 | 131 | 8 | GO:0002221 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-18-mediated signaling pathway | 5.91e-04 | 6 | 131 | 2 | GO:2000492 | |
| GeneOntologyBiologicalProcess | protein maturation | RGPD4 RGPD2 RANBP2 RGPD8 CASP4 CASP5 GLG1 RGPD3 IKBKB HSPA6 HSPA8 TBCD | 5.92e-04 | 619 | 131 | 12 | GO:0051604 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | RGPD4 RGPD2 RANBP2 RGPD8 SWAP70 SIRT1 GRK1 CCND2 ROPN1L SMG8 LONP1 CCNB3 RGPD3 PRKCE PRKDC TNFRSF1A IKBKB PPP1R42 BANK1 NR1H4 | 6.40e-04 | 1421 | 131 | 20 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of canonical NF-kappaB signal transduction | 6.44e-04 | 298 | 131 | 8 | GO:0043122 | |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | RGPD4 RGPD2 RANBP2 RGPD8 SWAP70 SIRT1 GRK1 CCND2 ROPN1L SMG8 LONP1 CCNB3 RGPD3 PRKCE PRKDC TNFRSF1A IKBKB PPP1R42 BANK1 NR1H4 | 6.51e-04 | 1423 | 131 | 20 | GO:0051174 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CKAP5 SIRT1 FSIP2 KATNBL1 DNAAF10 TTLL11 SYNE2 DNAAF6 DIAPH3 HYDIN TBCD DNM2 KIF2C | 6.79e-04 | 720 | 131 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | detection of lipopolysaccharide | 8.23e-04 | 7 | 131 | 2 | GO:0032497 | |
| GeneOntologyBiologicalProcess | negative regulation of triglyceride biosynthetic process | 8.23e-04 | 7 | 131 | 2 | GO:0010868 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 8.68e-04 | 312 | 131 | 8 | GO:0002758 | |
| GeneOntologyBiologicalProcess | cilium organization | ARL13A ARHGAP35 RFX3 FSIP2 EXOC5 DNAAF10 SYNE2 DNAAF6 HYDIN DNM2 | 9.35e-04 | 476 | 131 | 10 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ANKRD31 DCDC1 ANP32B VASH1 TRIM39 SMC5 SIRT1 CCND2 WIZ CCNB3 CDC16 PRKCE PSME3 PRKDC DIAPH3 RPA4 HSPA8 KIF2C | 9.94e-04 | 1256 | 131 | 18 | GO:0051726 |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 1.00e-03 | 319 | 131 | 8 | GO:0051222 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 5.75e-10 | 8 | 135 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.56e-09 | 10 | 135 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.25e-09 | 21 | 135 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.99e-08 | 14 | 135 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 8.35e-08 | 18 | 135 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.50e-07 | 20 | 135 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 RGPD2 RANBP2 RGPD8 ICE1 PRPF8 BAHD1 SIRT1 PHC1 MED15 BPTF NOP14 UPF2 CDC16 RGPD3 SYNE2 PRKDC TAF2 MED23 HSPA6 RPA4 HSPA8 ELP4 NR1H4 RGPD5 | 2.28e-06 | 1377 | 135 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | non-canonical inflammasome complex | 4.14e-05 | 2 | 135 | 2 | GO:0160074 | |
| GeneOntologyCellularComponent | transferase complex | RGPD4 PRPSAP1 RGPD2 RANBP2 RGPD8 SMC5 SIRT1 PHC1 CHUK CCND2 CCNB3 LMO7 CDC16 RGPD3 PRKDC TAF2 IKBKB MED23 | 4.87e-05 | 963 | 135 | 18 | GO:1990234 |
| GeneOntologyCellularComponent | nuclear pore | 4.97e-05 | 101 | 135 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear membrane | RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 CCND2 SEPHS1 TMEM120A RGPD3 SYNE2 | 9.20e-05 | 349 | 135 | 10 | GO:0031965 |
| GeneOntologyCellularComponent | canonical inflammasome complex | 2.00e-04 | 18 | 135 | 3 | GO:0061702 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 CCND2 SEPHS1 TMEM120A LMO7 RGPD3 SYNE2 RGPD5 | 2.83e-04 | 560 | 135 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | microtubule organizing center | EPS8L2 WRN CKAP5 ARHGAP35 CCND2 KATNBL1 CCNB3 GLG1 CDC16 TTLL11 DIAPH3 HSPA6 PPP1R42 TBCD DNM2 KIF2C | 2.94e-04 | 919 | 135 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | inclusion body | 2.95e-04 | 90 | 135 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | NLRP1 inflammasome complex | 6.11e-04 | 6 | 135 | 2 | GO:0072558 | |
| GeneOntologyCellularComponent | IkappaB kinase complex | 1.13e-03 | 8 | 135 | 2 | GO:0008385 | |
| GeneOntologyCellularComponent | small-subunit processome | 1.49e-03 | 76 | 135 | 4 | GO:0032040 | |
| GeneOntologyCellularComponent | CD40 receptor complex | 2.19e-03 | 11 | 135 | 2 | GO:0035631 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 7.31e-08 | 16 | 101 | 5 | MP:0003701 | |
| MousePheno | failure of blastocyst formation | 7.79e-08 | 31 | 101 | 6 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 3.29e-07 | 39 | 101 | 6 | MP:0012128 | |
| MousePheno | abnormal palate morphology | HIC1 ANP32B WRN CKAP5 SMOC1 SLC7A7 SIRT1 PHC1 CHUK WIZ GLG1 PAK1IP1 DNM2 | 5.15e-07 | 321 | 101 | 13 | MP:0003755 |
| MousePheno | increased hepatocellular carcinoma incidence | 6.88e-07 | 70 | 101 | 7 | MP:0003331 | |
| MousePheno | increased respiratory system tumor incidence | 1.01e-06 | 107 | 101 | 8 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 1.01e-06 | 107 | 101 | 8 | MP:0008014 | |
| MousePheno | abnormal morula morphology | 1.04e-06 | 26 | 101 | 5 | MP:0012058 | |
| MousePheno | increased lung carcinoma incidence | 1.45e-06 | 78 | 101 | 7 | MP:0008714 | |
| MousePheno | decreased tumor latency | 2.20e-06 | 30 | 101 | 5 | MP:0010308 | |
| MousePheno | abnormal rod electrophysiology | 2.27e-06 | 119 | 101 | 8 | MP:0004021 | |
| MousePheno | abnormal chromosome number | 2.81e-06 | 86 | 101 | 7 | MP:0004023 | |
| MousePheno | abnormal tumor latency | 4.20e-06 | 34 | 101 | 5 | MP:0010307 | |
| MousePheno | aneuploidy | 4.93e-06 | 61 | 101 | 6 | MP:0004024 | |
| MousePheno | cleft palate | ANP32B WRN CKAP5 SMOC1 SLC7A7 PHC1 CHUK WIZ GLG1 PAK1IP1 DNM2 | 7.44e-06 | 289 | 101 | 11 | MP:0000111 |
| MousePheno | oral cleft | ANP32B WRN CKAP5 SMOC1 SLC7A7 PHC1 CHUK WIZ GLG1 PAK1IP1 DNM2 | 7.94e-06 | 291 | 101 | 11 | MP:0021164 |
| MousePheno | increased carcinoma incidence | 1.25e-05 | 197 | 101 | 9 | MP:0002038 | |
| MousePheno | increased hepatobiliary system tumor incidence | 1.53e-05 | 111 | 101 | 7 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 1.53e-05 | 111 | 101 | 7 | MP:0008019 | |
| MousePheno | abnormal chromosome morphology | 3.49e-05 | 126 | 101 | 7 | MP:0003702 | |
| MousePheno | abnormal mitosis | 3.86e-05 | 128 | 101 | 7 | MP:0004046 | |
| MousePheno | decreased circulating interleukin-1 beta level | 3.96e-05 | 27 | 101 | 4 | MP:0008642 | |
| MousePheno | increased malignant tumor incidence | 5.36e-05 | 237 | 101 | 9 | MP:0002018 | |
| MousePheno | abnormal cell nucleus morphology | 5.51e-05 | 184 | 101 | 8 | MP:0003111 | |
| MousePheno | enlarged epididymis | 7.98e-05 | 99 | 101 | 6 | MP:0004931 | |
| MousePheno | abnormal mouth morphology | HIC1 DSP ANP32B WRN CKAP5 SMOC1 SLC7A7 SIRT1 PHC1 CHUK ROPN1L WIZ GLG1 PAK1IP1 DNM2 | 8.87e-05 | 670 | 101 | 15 | MP:0000452 |
| MousePheno | decreased circulating interleukin-1 level | 8.94e-05 | 33 | 101 | 4 | MP:0008592 | |
| MousePheno | increased sarcoma incidence | 9.42e-05 | 102 | 101 | 6 | MP:0002032 | |
| MousePheno | increased classified tumor incidence | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 CHUK LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 9.43e-05 | 381 | 101 | 11 | MP:0010273 |
| MousePheno | decreased macrophage apoptosis | 9.93e-05 | 13 | 101 | 3 | MP:0011081 | |
| MousePheno | abnormal classified tumor incidence | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 CHUK LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 1.01e-04 | 384 | 101 | 11 | MP:0020188 |
| MousePheno | increased tumor incidence | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 ANP32B WRN CHUK LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 1.11e-04 | 530 | 101 | 13 | MP:0002020 |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.23e-04 | 107 | 101 | 6 | MP:0003694 | |
| MousePheno | increased organ/body region tumor incidence | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 CHUK LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 1.30e-04 | 395 | 101 | 11 | MP:0010274 |
| MousePheno | abnormal organ/body region tumor incidence | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 CHUK LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 1.48e-04 | 401 | 101 | 11 | MP:0013152 |
| MousePheno | abnormal blastocyst hatching | 1.66e-04 | 113 | 101 | 6 | MP:0003693 | |
| MousePheno | abnormal tumor incidence | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 ANP32B WRN CHUK LONP1 LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 1.83e-04 | 635 | 101 | 14 | MP:0002019 |
| MousePheno | abnormal tumor susceptibility | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 ANP32B WRN CHUK LONP1 LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 2.33e-04 | 650 | 101 | 14 | MP:0002166 |
| MousePheno | abnormal preimplantation embryo development | 2.37e-04 | 171 | 101 | 7 | MP:0009781 | |
| MousePheno | abnormal eye electrophysiology | 2.43e-04 | 228 | 101 | 8 | MP:0005551 | |
| MousePheno | abnormal craniofacial morphology | HIC1 EPS8L2 DSP ANP32B WRN CKAP5 SMOC1 SLC7A7 SIRT1 TNFRSF11B PHC1 CHUK CCND2 ROPN1L WIZ UBR5 GLG1 DIAPH3 PAK1IP1 MED23 HYDIN DNM2 | 2.63e-04 | 1372 | 101 | 22 | MP:0000428 |
| MousePheno | craniofacial phenotype | HIC1 EPS8L2 DSP ANP32B WRN CKAP5 SMOC1 SLC7A7 SIRT1 TNFRSF11B PHC1 CHUK CCND2 ROPN1L WIZ UBR5 GLG1 DIAPH3 PAK1IP1 MED23 HYDIN DNM2 | 2.63e-04 | 1372 | 101 | 22 | MP:0005382 |
| MousePheno | neoplasm | RGPD4 RGPD2 RANBP2 HIC1 RGPD8 ANP32B WRN CHUK TGM2 LONP1 LMO7 RGPD3 PRKDC TNFRSF1A NR1H4 | 2.92e-04 | 747 | 101 | 15 | MP:0002006 |
| MousePheno | abnormal snout morphology | 5.42e-04 | 257 | 101 | 8 | MP:0000443 | |
| MousePheno | increased incidence of tumors by chemical induction | 5.47e-04 | 141 | 101 | 6 | MP:0004499 | |
| MousePheno | abnormal intracellular organelle morphology | RGPD4 RGPD2 RANBP2 RGPD8 ANP32B SPG11 SIRT1 LONP1 DNAJC11 RGPD3 SYNE2 DNM2 | 5.61e-04 | 546 | 101 | 12 | MP:0014239 |
| MousePheno | embryonic lethality before implantation, complete penetrance | 6.67e-04 | 203 | 101 | 7 | MP:0011094 | |
| MousePheno | abnormal embryo development | RGPD4 RGPD2 RANBP2 RGPD8 DSP CKAP5 ARHGAP35 SLC7A7 PRPF8 RFX3 CHUK ESCO2 BPTF LONP1 SEPHS1 UBR5 RGPD3 EIF5B SECISBP2 DIAPH3 MED23 | 6.79e-04 | 1370 | 101 | 21 | MP:0001672 |
| MousePheno | abnormal macrophage apoptosis | 7.50e-04 | 25 | 101 | 3 | MP:0011073 | |
| MousePheno | abnormal lymphocyte morphology | EPS8L2 COPA SWAP70 TRIM39 PARVB SMOC1 TST SLC7A7 SMC5 BAHD1 SIRT1 TNFRSF11B PHC1 DNAJC11 SECISBP2 PRKCE PSME3 PRKDC TNFRSF1A IKBKB BANK1 IL7R | 7.70e-04 | 1483 | 101 | 22 | MP:0002619 |
| MousePheno | abnormal facial morphology | HIC1 EPS8L2 DSP ANP32B WRN CKAP5 SMOC1 SLC7A7 SIRT1 PHC1 CHUK ROPN1L WIZ GLG1 PAK1IP1 DNM2 | 7.82e-04 | 910 | 101 | 16 | MP:0003743 |
| MousePheno | decreased memory T cell number | 9.18e-04 | 60 | 101 | 4 | MP:0008050 | |
| MousePheno | abnormal prenatal body size | HIC1 DSP CKAP5 ARHGAP35 SMOC1 SLC7A7 PRPF8 SIRT1 BPTF LONP1 SEPHS1 KIDINS220 WIZ UBR5 GLG1 DIAPH3 PAK1IP1 MED23 | 9.78e-04 | 1116 | 101 | 18 | MP:0010866 |
| MousePheno | decreased double-positive T cell number | 1.01e-03 | 106 | 101 | 5 | MP:0005092 | |
| MousePheno | abnormal preimplantation embryo morphology | 1.02e-03 | 283 | 101 | 8 | MP:0014137 | |
| MousePheno | abnormal secondary palate morphology | 1.03e-03 | 159 | 101 | 6 | MP:0013550 | |
| MousePheno | abnormal circulating interleukin-1 beta level | 1.04e-03 | 62 | 101 | 4 | MP:0008640 | |
| MousePheno | decreased circulating interleukin-1 alpha level | 1.06e-03 | 7 | 101 | 2 | MP:0008639 | |
| MousePheno | proteinosis | 1.06e-03 | 7 | 101 | 2 | MP:0010999 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.09e-03 | 286 | 101 | 8 | MP:0008873 | |
| MousePheno | increased macrophage cell number | 1.13e-03 | 162 | 101 | 6 | MP:0005425 | |
| MousePheno | abnormal epididymis size | 1.28e-03 | 166 | 101 | 6 | MP:0004926 | |
| MousePheno | abnormal cell cycle | RGPD4 ANKRD31 RGPD2 RANBP2 RGPD8 SIRT1 ESCO2 CCNB3 RGPD3 PSME3 DIAPH3 | 1.31e-03 | 520 | 101 | 11 | MP:0003077 |
| MousePheno | decreased interleukin-1 alpha secretion | 1.41e-03 | 8 | 101 | 2 | MP:0008655 | |
| MousePheno | liver degeneration | 1.42e-03 | 31 | 101 | 3 | MP:0003103 | |
| Domain | Ran_BP1 | 1.09e-10 | 12 | 134 | 6 | PF00638 | |
| Domain | RANBD1 | 1.09e-10 | 12 | 134 | 6 | PS50196 | |
| Domain | RanBD | 2.01e-10 | 13 | 134 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 2.01e-10 | 13 | 134 | 6 | IPR000156 | |
| Domain | Grip | 7.87e-09 | 11 | 134 | 5 | SM00755 | |
| Domain | GRIP | 7.87e-09 | 11 | 134 | 5 | PF01465 | |
| Domain | TPR-contain_dom | RGPD4 RGPD2 RANBP2 RGPD8 LONRF1 TTC3 CDC16 RGPD3 PDCD11 PRKDC RGPD5 | 1.09e-08 | 150 | 134 | 11 | IPR013026 |
| Domain | GRIP_dom | 1.34e-08 | 12 | 134 | 5 | IPR000237 | |
| Domain | GRIP | 1.34e-08 | 12 | 134 | 5 | PS50913 | |
| Domain | Rab_bind | 8.72e-08 | 7 | 134 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 8.72e-08 | 7 | 134 | 4 | IPR032023 | |
| Domain | TPR_REGION | RGPD4 RGPD2 RANBP2 RGPD8 LONRF1 TTC3 CDC16 RGPD3 PRKDC RGPD5 | 3.14e-07 | 165 | 134 | 10 | PS50293 |
| Domain | TPR | RGPD4 RGPD2 RANBP2 RGPD8 LONRF1 TTC3 CDC16 RGPD3 PRKDC RGPD5 | 3.14e-07 | 165 | 134 | 10 | PS50005 |
| Domain | - | 5.15e-07 | 10 | 134 | 4 | 1.10.220.60 | |
| Domain | TPR-like_helical_dom | RGPD4 RGPD2 RANBP2 RGPD8 LONRF1 TTC3 CDC16 RGPD3 PDCD11 PRKDC RGPD5 | 9.62e-07 | 233 | 134 | 11 | IPR011990 |
| Domain | TPR | 4.19e-06 | 129 | 134 | 8 | SM00028 | |
| Domain | TPR_repeat | 5.26e-06 | 133 | 134 | 8 | IPR019734 | |
| Domain | - | 1.87e-05 | 207 | 134 | 9 | 1.25.40.10 | |
| Domain | IKKbetaNEMObind | 5.11e-05 | 2 | 134 | 2 | PF12179 | |
| Domain | IKKbetaNEMObind | 5.11e-05 | 2 | 134 | 2 | SM01239 | |
| Domain | IKKbetaNEMObind | 5.11e-05 | 2 | 134 | 2 | IPR022007 | |
| Domain | TPR_1 | 4.76e-04 | 90 | 134 | 5 | IPR001440 | |
| Domain | TPR_1 | 4.76e-04 | 90 | 134 | 5 | PF00515 | |
| Domain | - | 5.53e-04 | 93 | 134 | 5 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 7.35e-04 | 99 | 134 | 5 | IPR011029 | |
| Domain | LON_substr_bdg | 7.52e-04 | 6 | 134 | 2 | PF02190 | |
| Domain | LON | 7.52e-04 | 6 | 134 | 2 | SM00464 | |
| Domain | LON_N | 7.52e-04 | 6 | 134 | 2 | PS51787 | |
| Domain | LON_substr-bd_dom | 7.52e-04 | 6 | 134 | 2 | IPR003111 | |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 IQSEC3 EPS8L2 RGPD8 SWAP70 RGPD3 DNM2 RGPD5 | 1.01e-03 | 426 | 134 | 10 | IPR011993 |
| Domain | Pept_C14A_CASP1-typ | 1.05e-03 | 7 | 134 | 2 | IPR017350 | |
| Domain | - | 2.06e-03 | 391 | 134 | 9 | 2.30.29.30 | |
| Domain | - | 2.24e-03 | 321 | 134 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 2.56e-03 | 328 | 134 | 8 | IPR032675 | |
| Domain | CASPASE_HIS | 2.69e-03 | 11 | 134 | 2 | PS01121 | |
| Domain | ARM-type_fold | 3.13e-03 | 339 | 134 | 8 | IPR016024 | |
| Domain | Caspase_his_AS | 3.22e-03 | 12 | 134 | 2 | IPR016129 | |
| Domain | CASPASE_CYS | 3.22e-03 | 12 | 134 | 2 | PS01122 | |
| Domain | Pept_C14_p10 | 3.22e-03 | 12 | 134 | 2 | IPR002138 | |
| Domain | Caspase_cys_AS | 3.22e-03 | 12 | 134 | 2 | IPR033139 | |
| Domain | - | 3.22e-03 | 12 | 134 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 3.22e-03 | 12 | 134 | 2 | IPR029047 | |
| Domain | CASPASE_P10 | 3.22e-03 | 12 | 134 | 2 | PS50207 | |
| Domain | LRR | 3.31e-03 | 201 | 134 | 6 | PS51450 | |
| Domain | Leu-rich_rpt | 3.44e-03 | 271 | 134 | 7 | IPR001611 | |
| Domain | CASc | 3.78e-03 | 13 | 134 | 2 | SM00115 | |
| Domain | - | 3.78e-03 | 13 | 134 | 2 | 1.20.1270.10 | |
| Domain | Pept_C14A | 3.78e-03 | 13 | 134 | 2 | IPR015917 | |
| Domain | Heat_shock_70_CS | 3.78e-03 | 13 | 134 | 2 | IPR018181 | |
| Domain | HSP70_C | 3.78e-03 | 13 | 134 | 2 | IPR029048 | |
| Domain | - | 4.39e-03 | 14 | 134 | 2 | 3.40.50.1460 | |
| Domain | Pept_C14_p20 | 4.39e-03 | 14 | 134 | 2 | IPR001309 | |
| Domain | Caspase-like_dom | 4.39e-03 | 14 | 134 | 2 | IPR029030 | |
| Domain | CASPASE_P20 | 4.39e-03 | 14 | 134 | 2 | PS50208 | |
| Domain | HEAT | 4.93e-03 | 48 | 134 | 3 | PF02985 | |
| Domain | CARD | 5.74e-03 | 16 | 134 | 2 | SM00114 | |
| Domain | HSP70 | 5.74e-03 | 16 | 134 | 2 | PF00012 | |
| Domain | HSP70_2 | 6.48e-03 | 17 | 134 | 2 | PS00329 | |
| Domain | Cyclin_C-dom | 6.48e-03 | 17 | 134 | 2 | IPR004367 | |
| Domain | HSP70_1 | 6.48e-03 | 17 | 134 | 2 | PS00297 | |
| Domain | Cyclin_C | 6.48e-03 | 17 | 134 | 2 | PF02984 | |
| Domain | HSP70_3 | 6.48e-03 | 17 | 134 | 2 | PS01036 | |
| Domain | Cyclin_C | 6.48e-03 | 17 | 134 | 2 | SM01332 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 8.98e-08 | 18 | 93 | 5 | MM1549 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 4.95e-07 | 73 | 93 | 7 | MM14948 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.00e-06 | 117 | 93 | 8 | MM15387 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.30e-06 | 84 | 93 | 7 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION | 1.68e-06 | 169 | 93 | 9 | MM14919 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.15e-06 | 58 | 93 | 6 | MM15149 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.40e-06 | 92 | 93 | 7 | MM14951 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.09e-06 | 141 | 93 | 8 | MM15266 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 4.21e-06 | 100 | 93 | 7 | MM14561 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.23e-06 | 65 | 93 | 6 | MM15147 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 5.01e-06 | 193 | 93 | 9 | MM14890 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.15e-06 | 40 | 93 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 6.96e-06 | 41 | 93 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 7.86e-06 | 42 | 93 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 8.85e-06 | 43 | 93 | 5 | MM14609 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.16e-05 | 271 | 93 | 10 | MM15388 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.38e-05 | 47 | 93 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.70e-05 | 49 | 93 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.88e-05 | 50 | 93 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.07e-05 | 51 | 93 | 5 | MM15151 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.25e-05 | 129 | 93 | 7 | MM14894 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.35e-05 | 234 | 93 | 9 | MM14898 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.01e-05 | 55 | 93 | 5 | MM14917 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.90e-05 | 58 | 93 | 5 | MM14736 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.19e-04 | 15 | 93 | 3 | MM1339 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.19e-04 | 15 | 93 | 3 | M47566 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.19e-04 | 15 | 93 | 3 | M10183 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY | 1.46e-04 | 16 | 93 | 3 | M47453 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.05e-04 | 82 | 93 | 5 | MM15394 | |
| Pathway | WP_APOPTOSIS | 2.17e-04 | 83 | 93 | 5 | MM15972 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 2.34e-04 | 46 | 93 | 4 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 2.34e-04 | 46 | 93 | 4 | MM1428 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.56e-04 | 86 | 93 | 5 | MM15413 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 2.93e-04 | 257 | 93 | 8 | MM14755 | |
| Pathway | BIOCARTA_NFKB_PATHWAY | 3.39e-04 | 21 | 93 | 3 | MM1444 | |
| Pathway | BIOCARTA_NFKB_PATHWAY | 3.39e-04 | 21 | 93 | 3 | M15285 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.74e-04 | 202 | 93 | 7 | MM15362 | |
| Pathway | PID_NFKAPPAB_CANONICAL_PATHWAY | 4.47e-04 | 23 | 93 | 3 | M37 | |
| Pathway | BIOCARTA_STRESS_PATHWAY | 5.09e-04 | 24 | 93 | 3 | MM1515 | |
| Pathway | BIOCARTA_STRESS_PATHWAY | 5.09e-04 | 24 | 93 | 3 | M9670 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RGPD2 RANBP2 RGPD8 WRN CKAP5 CCND2 ESCO2 CDC16 RGPD3 PSME3 KIF2C | 5.90e-04 | 603 | 93 | 12 | MM14635 |
| Pathway | REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION | 6.35e-04 | 6 | 93 | 2 | M48272 | |
| Pathway | REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION | 6.35e-04 | 6 | 93 | 2 | MM17244 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY | 6.35e-04 | 6 | 93 | 2 | M47462 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | RGPD4 RGPD2 RANBP2 RGPD8 PRPF8 SMG8 NOP14 UPF2 RGPD3 PDCD11 PSME3 HSPA8 | 6.72e-04 | 612 | 93 | 12 | MM15547 |
| Pathway | KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY | 8.85e-04 | 7 | 93 | 2 | M47651 | |
| Pathway | REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID | 8.85e-04 | 7 | 93 | 2 | M27463 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY | 8.85e-04 | 7 | 93 | 2 | M47464 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 9.35e-04 | 114 | 93 | 5 | MM15361 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 9.90e-04 | 67 | 93 | 4 | M10462 | |
| Pathway | REACTOME_M_PHASE | 1.02e-03 | 387 | 93 | 9 | MM15364 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RGPD2 RANBP2 RGPD8 SWAP70 DSP CKAP5 ARHGAP35 KIDINS220 RGPD3 DIAPH3 KIF2C | 1.12e-03 | 649 | 93 | 12 | MM15690 |
| Pathway | WP_CANONICAL_NFKB_PATHWAY | 1.17e-03 | 8 | 93 | 2 | M39783 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.17e-03 | 8 | 93 | 2 | M47463 | |
| Pathway | REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY | 1.31e-03 | 33 | 93 | 3 | M27438 | |
| Pathway | REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY | 1.31e-03 | 33 | 93 | 3 | MM15180 | |
| Pathway | WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT | 1.50e-03 | 9 | 93 | 2 | M39757 | |
| Pathway | WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD | 1.50e-03 | 9 | 93 | 2 | M39509 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY | 1.50e-03 | 9 | 93 | 2 | M47652 | |
| Pathway | WP_NODLIKE_RECEPTOR_NLR_SIGNALING | 1.50e-03 | 9 | 93 | 2 | M39494 | |
| Pathway | WP_NODLIKE_RECEPTOR_NLR_SIGNALING_PATHWAY | 1.50e-03 | 9 | 93 | 2 | MM15889 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY | 1.50e-03 | 9 | 93 | 2 | M47734 | |
| Pathway | REACTOME_SUMOYLATION | 1.56e-03 | 189 | 93 | 6 | M27214 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING | 1.56e-03 | 35 | 93 | 3 | M39529 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.66e-03 | 77 | 93 | 4 | M27226 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 1.70e-03 | 36 | 93 | 3 | M1059 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY | 1.87e-03 | 10 | 93 | 2 | M47599 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY | 1.87e-03 | 10 | 93 | 2 | M47601 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 1.87e-03 | 10 | 93 | 2 | M39469 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 2.05e-03 | 136 | 93 | 5 | M42547 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.10e-03 | 82 | 93 | 4 | M27250 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY | 2.28e-03 | 11 | 93 | 2 | M47493 | |
| Pathway | WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA | 2.30e-03 | 40 | 93 | 3 | M48337 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.36e-03 | 277 | 93 | 7 | MM15414 | |
| Pathway | WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY | 2.47e-03 | 41 | 93 | 3 | M39698 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 2.65e-03 | 42 | 93 | 3 | M41828 | |
| Pathway | WP_APOPTOSIS | 2.71e-03 | 88 | 93 | 4 | M39654 | |
| Pathway | WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ | 2.72e-03 | 12 | 93 | 2 | M39552 | |
| Pathway | WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS | 2.72e-03 | 12 | 93 | 2 | MM15927 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY | 2.72e-03 | 12 | 93 | 2 | M47600 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 2.83e-03 | 43 | 93 | 3 | MM15679 | |
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 COPA DSP PCDHGA3 SPG11 PRPF8 TTC3 FER1L6 CHUK ACSL4 BPTF SEPHS1 C6orf118 NOP14 SUGCT LMO7 SNX25 DNAJC11 RGPD3 SYNE2 EIF5B PRKDC DIAPH3 HSPA6 HSPA8 RGPD5 | 2.89e-13 | 1442 | 136 | 29 | 35575683 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 EPS8L2 COPA DSP CKAP5 PARVB PRPF8 EXOC5 WIZ XPO5 LMO7 CDC16 PRKDC DIAPH3 HSPA6 HSPA8 DNM2 KIF2C | 1.60e-11 | 582 | 136 | 18 | 20467437 |
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.77e-11 | 7 | 136 | 5 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.77e-11 | 7 | 136 | 5 | 11353387 | |
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 30944974 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.77e-11 | 7 | 136 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.77e-11 | 7 | 136 | 5 | 17372272 | |
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 38657106 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 21205196 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 18949001 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 25187515 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 8603673 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 26632511 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 24403063 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 23818861 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 23536549 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 12191015 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 22821000 | ||
| Pubmed | 1.77e-11 | 7 | 136 | 5 | 20682751 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | RGPD4 RGPD2 RANBP2 RGPD8 PRPF8 SIRT1 UBR5 DNAAF10 CDC16 RGPD3 HSPA8 | 2.52e-11 | 153 | 136 | 11 | 26365490 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.71e-11 | 8 | 136 | 5 | 21670213 | |
| Pubmed | 4.71e-11 | 8 | 136 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.71e-11 | 8 | 136 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.71e-11 | 8 | 136 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.71e-11 | 8 | 136 | 5 | 28745977 | |
| Pubmed | SWAP70 DSP ARHGAP35 MED15 BPTF WIZ LMO7 CDC16 PDCD11 PSME3 PRKDC TAF2 DIAPH3 MED23 HSPA6 ELP4 RGPD5 | 6.00e-11 | 549 | 136 | 17 | 38280479 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.06e-10 | 9 | 136 | 5 | 18394993 | |
| Pubmed | 1.06e-10 | 9 | 136 | 5 | 28100513 | ||
| Pubmed | 1.06e-10 | 9 | 136 | 5 | 17887960 | ||
| Pubmed | 1.06e-10 | 9 | 136 | 5 | 11553612 | ||
| Pubmed | 1.06e-10 | 9 | 136 | 5 | 10601307 | ||
| Pubmed | 1.06e-10 | 9 | 136 | 5 | 9733766 | ||
| Pubmed | 1.06e-10 | 9 | 136 | 5 | 28877029 | ||
| Pubmed | RGPD4 RGPD2 KDM5B RANBP2 RGPD8 TRIML2 DSP CKAP5 ICE1 PHC1 WIZ UBR5 RGPD3 DIAPH3 HSPA6 | 1.13e-10 | 418 | 136 | 15 | 34709266 | |
| Pubmed | 2.11e-10 | 10 | 136 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.11e-10 | 10 | 136 | 5 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.11e-10 | 10 | 136 | 5 | 8857542 | |
| Pubmed | 2.11e-10 | 10 | 136 | 5 | 21859863 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RGPD2 RANBP2 RGPD8 CKAP5 NOL10 MED15 ACSL4 BPTF NOP14 WIZ RGPD3 PSME3 DNM2 | 2.45e-10 | 370 | 136 | 14 | 22922362 |
| Pubmed | 3.85e-10 | 11 | 136 | 5 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 3.85e-10 | 11 | 136 | 5 | 35771867 | |
| Pubmed | 3.85e-10 | 11 | 136 | 5 | 34110283 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | RANBP2 SWAP70 DSP CKAP5 PRPF8 KIDINS220 LMO7 EIF5B PRKDC DIAPH3 HSPA8 ELP4 | 4.42e-10 | 256 | 136 | 12 | 33397691 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.07e-09 | 13 | 136 | 5 | 31427429 | |
| Pubmed | 1.82e-09 | 86 | 136 | 8 | 37253089 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 2.46e-09 | 179 | 136 | 10 | 36261009 | |
| Pubmed | 2.47e-09 | 15 | 136 | 5 | 14697343 | ||
| Pubmed | RANBP2 COPA ANP32B SMC5 PRPF8 SIRT1 MED15 BPTF LONP1 UBR5 XPO5 CDC16 ZNF451 EIF5B PSME3 PRKDC TAF2 PAK1IP1 METTL16 MED23 | 2.98e-09 | 1014 | 136 | 20 | 32416067 | |
| Pubmed | PRPSAP1 RANBP2 EPS8L2 COPA DSP IARS1 PRPF8 ACSL4 LONP1 LMO7 GLG1 DNAJC11 PDCD11 PRKDC METTL16 HSPA8 DNM2 | 3.03e-09 | 711 | 136 | 17 | 33022573 | |
| Pubmed | RANBP2 COPA DSP CKAP5 NOL10 PRPF8 BPTF LONP1 NOP14 UBR5 XPO5 SYNE2 EIF5B PDCD11 PRKDC DNM2 | 6.48e-09 | 653 | 136 | 16 | 22586326 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 FOXN2 COPA DSP IARS1 CKAP5 PRPF8 RFX3 CHUK ACSL4 BPTF IFRD1 NOP14 WIZ UBR5 EIF5B HSPA8 KIF2C | 7.55e-09 | 857 | 136 | 18 | 25609649 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 COPA DSP IARS1 CKAP5 NOL10 PRPF8 ACSL4 TGM2 SMG8 LONP1 NOP14 UPF2 UBR5 EIF5B PDCD11 PSME3 PRKDC TAF2 HSPA6 HSPA8 KIF2C | 1.49e-08 | 1353 | 136 | 22 | 29467282 |
| Pubmed | 2.12e-08 | 22 | 136 | 5 | 27717094 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANBP2 COPA SWAP70 IARS1 CKAP5 ARHGAP35 SMC5 PRPF8 TTC3 WIZ UPF2 LMO7 EIF5B SECISBP2 TAF2 DIAPH3 | 2.72e-08 | 724 | 136 | 16 | 36232890 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NMNAT1 COPA WRN CKAP5 NOL10 SMC5 PRPF8 BPTF EXOC5 NOP14 UPF2 PDCD11 PRKDC PAK1IP1 MED23 KIF2C | 5.21e-08 | 759 | 136 | 16 | 35915203 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 PRPSAP1 RGPD2 RANBP2 RGPD8 COPA IARS1 CKAP5 PRPF8 ACSL4 LONP1 RGPD3 PSME3 HSPA8 TBCD | 5.85e-08 | 665 | 136 | 15 | 30457570 |
| Pubmed | 5.85e-08 | 3 | 136 | 3 | 9632806 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 6.48e-08 | 135 | 136 | 8 | 31077711 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANBP2 COPA IARS1 CKAP5 PRPF8 BPTF XPO5 LMO7 PRKDC HSPA8 KIF2C | 8.57e-08 | 332 | 136 | 11 | 32786267 |
| Pubmed | RANBP2 WRN CKAP5 NOL10 ICE1 MED15 IFRD1 TMEM120A KIDINS220 NOP14 WIZ GLG1 CDC16 DNAJC11 RGPD3 EIF5B PDCD11 TAF2 PAK1IP1 MED23 HSPA6 KIF2C | 8.80e-08 | 1497 | 136 | 22 | 31527615 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.11e-07 | 202 | 136 | 9 | 33005030 | |
| Pubmed | 1.11e-07 | 202 | 136 | 9 | 24639526 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.19e-07 | 146 | 136 | 8 | 23892456 | |
| Pubmed | COPA ANP32B IARS1 CKAP5 PRPF8 TGM2 KIDINS220 XPO5 CLIC2 EIF5B PSME3 PRKDC HSPA8 DNM2 KIF2C | 1.29e-07 | 707 | 136 | 15 | 19738201 | |
| Pubmed | 1.32e-07 | 99 | 136 | 7 | 27746211 | ||
| Pubmed | EPS8L2 COPA SWAP70 DSP IARS1 PRPF8 BPTF KIDINS220 UBR5 XPO5 GLG1 SYNE2 EIF5B PDCD11 PRKDC DIAPH3 IKBKB HSPA6 HSPA8 DNM2 | 1.70e-07 | 1297 | 136 | 20 | 33545068 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 COPA DSP ANP32B IARS1 CKAP5 NOL10 PRPF8 TTC3 LONP1 KIDINS220 XPO5 CDC16 DNAJC11 EIF5B PDCD11 PSME3 PRKDC PAK1IP1 MED23 HSPA8 | 1.71e-07 | 1425 | 136 | 21 | 30948266 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RANBP2 COPA IARS1 WRN NOL10 PARVB PRPF8 TGM2 LONP1 NOP14 UPF2 XPO5 DNAJC11 EIF5B PDCD11 PRKDC PAK1IP1 HSPA8 DNM2 KIF2C | 2.19e-07 | 1318 | 136 | 20 | 30463901 |
| Pubmed | RANBP2 COPA IARS1 CKAP5 PRPF8 LONP1 XPO5 EIF5B PDCD11 PSME3 PRKDC HSPA6 HSPA8 DNM2 | 2.31e-07 | 638 | 136 | 14 | 33239621 | |
| Pubmed | Innate immune-directed NF-κB signaling requires site-specific NEMO ubiquitination. | 2.33e-07 | 4 | 136 | 3 | 23871670 | |
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 10898787 | ||
| Pubmed | IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. | 2.33e-07 | 4 | 136 | 3 | 20026656 | |
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 9480752 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 RGPD2 RANBP2 COPA DSP IARS1 CHUK ACSL4 TGM2 UBR5 LMO7 PRKDC HSPA8 DNM2 | 2.74e-07 | 647 | 136 | 14 | 26618866 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.88e-07 | 226 | 136 | 9 | 37839992 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.84e-07 | 38 | 136 | 5 | 12791264 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NMNAT1 COPA DSP IARS1 CKAP5 NOL10 PRPF8 TGM2 NOP14 UPF2 LMO7 CDC16 DNAJC11 EIF5B PDCD11 PRKDC PAK1IP1 HSPA8 KIF2C | 4.82e-07 | 1257 | 136 | 19 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 PRPSAP1 RGPD2 RANBP2 RGPD8 COPA DSP IARS1 PRPF8 UBR5 DNAJC11 RGPD3 PSME3 PRKDC HSPA6 HSPA8 TBCD DNM2 RGPD5 | 4.82e-07 | 1257 | 136 | 19 | 37317656 |
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 32332915 | ||
| Pubmed | IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma. | 5.82e-07 | 5 | 136 | 3 | 29588349 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 6.41e-07 | 182 | 136 | 8 | 32239614 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP1 RANBP2 COPA DSP ANP32B IARS1 CKAP5 ARHGAP35 PRPF8 LONP1 UBR5 GLG1 DNAAF10 SYNE2 EIF5B PSME3 PRKDC DIAPH3 HSPA6 HSPA8 | 6.68e-07 | 1415 | 136 | 20 | 28515276 |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 10755617 | ||
| Pubmed | Sirt-1 is required for the inhibition of apoptosis and inflammatory responses in human tenocytes. | 1.16e-06 | 6 | 136 | 3 | 22689577 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 14966265 | ||
| Pubmed | Epithelial NEMO links innate immunity to chronic intestinal inflammation. | 1.16e-06 | 6 | 136 | 3 | 17361131 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 30737145 | ||
| Pubmed | PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination. | 1.16e-06 | 6 | 136 | 3 | 19150425 | |
| Pubmed | 1.16e-06 | 197 | 136 | 8 | 31620119 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B RANBP2 COPA DSP ARHGAP35 PRPF8 BPTF KIDINS220 NOP14 WIZ UPF2 EIF5B PRKDC PAK1IP1 MED23 HSPA6 HSPA8 | 1.21e-06 | 1082 | 136 | 17 | 38697112 |
| Pubmed | COPA DSP IARS1 CKAP5 NOP14 EIF5B PSME3 PRKDC HSPA6 HSPA8 DNM2 | 1.42e-06 | 441 | 136 | 11 | 31239290 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | DSP IARS1 CKAP5 PRPF8 ADGRG4 CCND2 ACSL4 LONP1 UBR5 CDC16 PSME3 PRKDC HSPA8 | 1.48e-06 | 639 | 136 | 13 | 23443559 |
| Pubmed | RANBP2 IARS1 CKAP5 SIRT1 MED15 BPTF NOP14 WIZ UBR5 XPO5 EIF5B PSME3 PRKDC MED23 HSPA8 DNM2 KIF2C | 1.57e-06 | 1103 | 136 | 17 | 34189442 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 COPA SWAP70 DSP IARS1 CKAP5 PRPF8 ACSL4 TGM2 SEPHS1 GLG1 SYNE2 EIF5B PDCD11 PSME3 PRKDC HSPA8 TBCD KIF2C | 1.67e-06 | 1367 | 136 | 19 | 32687490 |
| Pubmed | COPA IARS1 CKAP5 NOL10 SMC5 LONP1 CDC16 EIF5B TAF2 MED23 ELP4 | 1.76e-06 | 451 | 136 | 11 | 30033366 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 21724995 | ||
| Pubmed | RGPD4 RGPD2 RANBP2 IQSEC3 RGPD8 DSP IARS1 CKAP5 ARHGAP35 LONP1 GLG1 CDC16 SNX25 DNAJC11 RGPD3 HSPA8 ELP4 | 2.41e-06 | 1139 | 136 | 17 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANBP2 COPA DSP ANP32B IARS1 CKAP5 PRPF8 SEPHS1 UBR5 XPO5 LMO7 DNAAF10 EIF5B PRKDC HSPA6 HSPA8 DNM2 | 2.71e-06 | 1149 | 136 | 17 | 35446349 |
| Interaction | CDC5L interactions | RANBP2 EPS8L2 NMNAT1 COPA DSP WRN CKAP5 PARVB SMC5 PRPF8 EXOC5 NOP14 UBR5 XPO5 LMO7 CDC16 ZNF451 PSME3 PRKDC HSPA6 RPA4 HSPA8 DNM2 KIF2C | 2.35e-09 | 855 | 135 | 24 | int:CDC5L |
| Interaction | RGPD4 interactions | 5.52e-09 | 22 | 135 | 6 | int:RGPD4 | |
| Interaction | RICTOR interactions | RGPD4 RGPD2 RGPD8 COPA DSP IARS1 CKAP5 SIRT1 CHUK ACSL4 TRIM66 TGM2 LONP1 WIZ UBR5 CDC16 RGPD3 PRKDC IKBKB RPA4 HSPA8 RGPD5 | 6.69e-09 | 759 | 135 | 22 | int:RICTOR |
| Interaction | RGPD2 interactions | 2.13e-08 | 27 | 135 | 6 | int:RGPD2 | |
| Interaction | CHAF1A interactions | RANBP2 ANP32B WRN SMC5 PRPF8 SIRT1 BPTF WIZ UBR5 DNAAF10 CDC16 PRKDC HSPA8 | 2.65e-07 | 322 | 135 | 13 | int:CHAF1A |
| Interaction | SLX4 interactions | RANBP2 DSP WRN SMC5 SIRT1 NOP14 WIZ UBR5 ZNF451 RGPD3 PDCD11 PRKDC MED23 HSPA6 RPA4 HSPA8 KIF2C | 2.89e-07 | 572 | 135 | 17 | int:SLX4 |
| Interaction | SUMO2 interactions | RANBP2 COPA TRIML2 ANP32B IARS1 WRN CKAP5 SMC5 PRPF8 SIRT1 BPTF XPO5 LMO7 ZNF451 PRKDC HSPA8 KIF2C | 4.56e-07 | 591 | 135 | 17 | int:SUMO2 |
| Interaction | SNW1 interactions | RANBP2 EPS8L2 COPA DSP CKAP5 PARVB SMC5 PRPF8 SIRT1 EXOC5 WIZ UBR5 PRKDC DIAPH3 HSPA6 RPA4 HSPA8 DNM2 KIF2C | 5.93e-07 | 747 | 135 | 19 | int:SNW1 |
| Interaction | RGPD3 interactions | 6.93e-07 | 47 | 135 | 6 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 8.92e-07 | 49 | 135 | 6 | int:RGPD1 | |
| Interaction | EED interactions | RANBP2 HIC1 EPS8L2 COPA DSP ANP32B IARS1 CKAP5 NOL10 SMC5 PRPF8 BAHD1 SIRT1 PHC1 ACSL4 BPTF NOP14 WIZ XPO5 EIF5B PDCD11 PRKDC METTL16 HSPA8 TBCD DNM2 KIF2C | 9.62e-07 | 1445 | 135 | 27 | int:EED |
| Interaction | NUP43 interactions | RANBP2 RGPD8 DSP WRN NOL10 ICE1 CCDC168 FSIP2 BPTF NOP14 UBR5 SYNE2 PDCD11 TAF2 HSPA6 ELP4 RGPD5 | 9.87e-07 | 625 | 135 | 17 | int:NUP43 |
| Interaction | CIT interactions | RANBP2 COPA DSP IARS1 PIH1D2 CKAP5 NOL10 PARVB SLC7A7 PRPF8 TTC3 ACSL4 BPTF LONP1 NLRP9 NOP14 XPO5 LMO7 RGPD3 SYNE2 EIF5B PDCD11 SECISBP2 PRKDC HSPA6 HSPA8 KIF2C | 1.03e-06 | 1450 | 135 | 27 | int:CIT |
| Interaction | PML interactions | RANBP2 TRIML2 WRN SMC5 SIRT1 MED15 ACSL4 TRIM66 LONP1 UBR5 LMO7 CDC16 ZNF451 DNAJC11 RGPD3 SYNE2 PSME3 MED23 HSPA6 HSPA8 DNM2 | 1.04e-06 | 933 | 135 | 21 | int:PML |
| Interaction | PARP1 interactions | PRPSAP1 SYCP2L SWAP70 ANP32B WRN NOL10 TST SMC5 PRPF8 SIRT1 PHC1 BPTF IFRD1 KIDINS220 NOP14 WIZ LMO7 ZNF451 PDCD11 PRKDC MED23 RPA4 HSPA8 TBCD DNM2 | 1.94e-06 | 1316 | 135 | 25 | int:PARP1 |
| Interaction | TRIM33 interactions | RANBP2 COPA DSP IARS1 CKAP5 SMC5 PRPF8 BPTF SUGCT CDC16 EIF5B PSME3 PRKDC HSPA8 | 2.20e-06 | 453 | 135 | 14 | int:TRIM33 |
| Interaction | PHLPP1 interactions | RANBP2 SWAP70 DSP CKAP5 PRPF8 KIDINS220 LMO7 EIF5B PRKDC DIAPH3 HSPA8 ELP4 | 2.56e-06 | 333 | 135 | 12 | int:PHLPP1 |
| Interaction | RAN interactions | RGPD4 RGPD2 RANBP2 RGPD8 DSP IARS1 SMC5 XPO5 RGPD3 IKBKB HSPA6 RPA4 HSPA8 RGPD5 | 3.82e-06 | 475 | 135 | 14 | int:RAN |
| Interaction | PIH1D1 interactions | RANBP2 COPA DSP ANP32B IARS1 PRPF8 LONP1 UBR5 GLG1 DNAAF10 DNAJC11 EIF5B PSME3 PRKDC HSPA6 RPA4 HSPA8 | 8.03e-06 | 731 | 135 | 17 | int:PIH1D1 |
| Interaction | SIRT7 interactions | RANBP2 COPA DSP CKAP5 NOL10 PRPF8 SIRT1 BPTF LONP1 NOP14 UBR5 XPO5 SYNE2 EIF5B PDCD11 PRKDC DNM2 | 1.01e-05 | 744 | 135 | 17 | int:SIRT7 |
| Interaction | LRRC31 interactions | 1.01e-05 | 205 | 135 | 9 | int:LRRC31 | |
| Interaction | RGPD8 interactions | 1.03e-05 | 74 | 135 | 6 | int:RGPD8 | |
| Interaction | LGR4 interactions | RGPD4 RANBP2 IARS1 PRPF8 TRIM66 KIDINS220 UPF2 EIF5B PDCD11 PRKDC | 1.10e-05 | 262 | 135 | 10 | int:LGR4 |
| Interaction | MAP4 interactions | 1.19e-05 | 324 | 135 | 11 | int:MAP4 | |
| Interaction | BRAF interactions | 1.32e-05 | 212 | 135 | 9 | int:BRAF | |
| Interaction | ABI1 interactions | 1.98e-05 | 223 | 135 | 9 | int:ABI1 | |
| Interaction | RANBP2 interactions | RGPD4 RGPD2 RANBP2 RGPD8 SMC5 PRPF8 RGPD3 PRKDC RPA4 HSPA8 RGPD5 | 3.23e-05 | 361 | 135 | 11 | int:RANBP2 |
| Interaction | CIMAP1C interactions | 3.41e-05 | 10 | 135 | 3 | int:CIMAP1C | |
| Interaction | FGFR1OP2 interactions | 4.06e-05 | 94 | 135 | 6 | int:FGFR1OP2 | |
| Interaction | RGPD5 interactions | 4.57e-05 | 96 | 135 | 6 | int:RGPD5 | |
| Interaction | KDF1 interactions | 4.63e-05 | 192 | 135 | 8 | int:KDF1 | |
| Interaction | SPDL1 interactions | 5.30e-05 | 315 | 135 | 10 | int:SPDL1 | |
| Interaction | NR2C2 interactions | RANBP2 COPA IARS1 WRN NOL10 PARVB SMC5 PRPF8 CHUK TGM2 LONP1 NOP14 UPF2 XPO5 DNAJC11 EIF5B PDCD11 PRKDC PAK1IP1 IKBKB HSPA8 DNM2 KIF2C | 5.57e-05 | 1403 | 135 | 23 | int:NR2C2 |
| Interaction | KDM1A interactions | KIAA0408 KDM5B RANBP2 TRIML2 DSP CKAP5 TRIM39 ICE1 BAHD1 PHC1 ESCO2 WIZ UBR5 XPO5 ZNF451 DIAPH3 MED23 HSPA6 | 5.77e-05 | 941 | 135 | 18 | int:KDM1A |
| Interaction | HSF1 interactions | RANBP2 COPA DSP IARS1 PRPF8 SIRT1 WIZ CDC16 SYNE2 EIF5B PRKDC MED23 HSPA8 KIF2C | 6.04e-05 | 609 | 135 | 14 | int:HSF1 |
| Interaction | COMTD1 interactions | 6.18e-05 | 200 | 135 | 8 | int:COMTD1 | |
| Interaction | NUP50 interactions | 1.02e-04 | 341 | 135 | 10 | int:NUP50 | |
| Interaction | RELA interactions | SIRT1 CHUK CCND2 MED15 TGM2 GLG1 PDCD11 PRKDC IKBKB MED23 HSPA6 HSPA8 | 1.05e-04 | 485 | 135 | 12 | int:RELA |
| Interaction | SMC1A interactions | COPA CKAP5 CASP4 SMC5 PRPF8 BPTF UBR5 PDCD11 PRKDC HSPA8 DNM2 | 1.20e-04 | 418 | 135 | 11 | int:SMC1A |
| Interaction | SRRM1 interactions | 1.21e-04 | 348 | 135 | 10 | int:SRRM1 | |
| Interaction | POLR1E interactions | RANBP2 NOL10 ICE1 SIRT1 NOP14 WIZ DNAAF10 EIF5B PDCD11 IKBKB | 1.27e-04 | 350 | 135 | 10 | int:POLR1E |
| Interaction | DSP interactions | DSP CKAP5 CASP4 SMC5 PRPF8 TTC3 UBR5 PRKCE PRKDC HSPA6 HSPA8 | 1.33e-04 | 423 | 135 | 11 | int:DSP |
| Interaction | WDR5 interactions | PRPSAP1 RANBP2 EPS8L2 COPA DSP IARS1 PRPF8 ACSL4 LONP1 UBR5 LMO7 GLG1 DNAJC11 PDCD11 PRKDC METTL16 HSPA8 DNM2 KIF2C | 1.38e-04 | 1101 | 135 | 19 | int:WDR5 |
| Interaction | SUMO1 interactions | 1.39e-04 | 287 | 135 | 9 | int:SUMO1 | |
| Interaction | AKIRIN2 interactions | 1.39e-04 | 74 | 135 | 5 | int:AKIRIN2 | |
| Interaction | ITGB3 interactions | 1.50e-04 | 170 | 135 | 7 | int:ITGB3 | |
| Interaction | ANKRD55 interactions | 1.53e-04 | 228 | 135 | 8 | int:ANKRD55 | |
| Interaction | PRODH interactions | 1.54e-04 | 16 | 135 | 3 | int:PRODH | |
| Interaction | VASH1 interactions | 1.54e-04 | 16 | 135 | 3 | int:VASH1 | |
| Interaction | FOXP3 interactions | RANBP2 CKAP5 NOL10 SIRT1 MED15 ACSL4 BPTF NOP14 WIZ PSME3 DNM2 | 1.60e-04 | 432 | 135 | 11 | int:FOXP3 |
| Interaction | PTEN interactions | RANBP2 COPA DSP ANP32B PRPF8 CHUK CCND2 FSIP2 TGM2 EXOC5 GLG1 PDCD11 PRKDC METTL16 HSPA6 HSPA8 KIF2C | 1.60e-04 | 929 | 135 | 17 | int:PTEN |
| Interaction | PRKCG interactions | 1.65e-04 | 121 | 135 | 6 | int:PRKCG | |
| Interaction | WAPL interactions | 1.67e-04 | 173 | 135 | 7 | int:WAPL | |
| Interaction | NCOR1 interactions | 1.70e-04 | 363 | 135 | 10 | int:NCOR1 | |
| Interaction | GYPA interactions | 1.74e-04 | 174 | 135 | 7 | int:GYPA | |
| Interaction | ANAPC2 interactions | 1.83e-04 | 234 | 135 | 8 | int:ANAPC2 | |
| Interaction | SOX2 interactions | KDM5B RANBP2 NMNAT1 COPA DSP ANP32B WRN CKAP5 PRPF8 TTC3 RFX3 BPTF LONP1 SEPHS1 KIDINS220 WIZ UBR5 XPO5 EIF5B PDCD11 TAF2 HSPA8 | 1.90e-04 | 1422 | 135 | 22 | int:SOX2 |
| Interaction | HDLBP interactions | NMNAT1 COPA DSP WRN SMC5 PRPF8 SIRT1 ACSL4 TGM2 UPF2 LMO7 ZNF451 PRKDC PAK1IP1 RPA4 HSPA8 | 1.97e-04 | 855 | 135 | 16 | int:HDLBP |
| Interaction | DUSP2 interactions | 2.13e-04 | 81 | 135 | 5 | int:DUSP2 | |
| Interaction | BIRC3 interactions | RANBP2 COPA DSP ANP32B IARS1 CKAP5 NOL10 PRPF8 TTC3 CHUK LONP1 XPO5 DNAJC11 EIF5B PDCD11 PSME3 PRKDC PAK1IP1 TNFRSF1A IKBKB HSPA8 | 2.14e-04 | 1334 | 135 | 21 | int:BIRC3 |
| Interaction | NPIPB6 interactions | 2.23e-04 | 18 | 135 | 3 | int:NPIPB6 | |
| Interaction | CENPA interactions | 2.31e-04 | 377 | 135 | 10 | int:CENPA | |
| Interaction | BRCA1 interactions | COPA DSP LONRF1 IARS1 WRN CKAP5 SMC5 ACSL4 BPTF TGM2 WIZ UBR5 CDC16 EIF5B PSME3 PRKDC IKBKB RPA4 HSPA8 KIF2C | 2.46e-04 | 1249 | 135 | 20 | int:BRCA1 |
| Interaction | FRMD8P1 interactions | 2.65e-04 | 4 | 135 | 2 | int:FRMD8P1 | |
| Interaction | RANGAP1 interactions | 2.71e-04 | 314 | 135 | 9 | int:RANGAP1 | |
| Interaction | PRC1 interactions | KDM5B RANBP2 EPS8L2 DSP SPG11 NOL10 PRPF8 ESCO2 LONP1 XPO5 LMO7 DNAAF10 RGPD3 EIF5B PDCD11 PRKDC RPA4 | 2.76e-04 | 973 | 135 | 17 | int:PRC1 |
| Interaction | CDC73 interactions | 2.79e-04 | 386 | 135 | 10 | int:CDC73 | |
| Interaction | C19orf38 interactions | 2.82e-04 | 86 | 135 | 5 | int:C19orf38 | |
| Interaction | BAG2 interactions | CKAP5 SPG11 ARHGAP35 PRPF8 PHC1 TRIM66 BPTF SMG8 WIZ DNAJC11 TAF2 HSPA8 TBCD | 2.84e-04 | 622 | 135 | 13 | int:BAG2 |
| Interaction | NR1I3 interactions | 2.98e-04 | 48 | 135 | 4 | int:NR1I3 | |
| Interaction | SIRT6 interactions | RANBP2 RGPD8 DSP PRPF8 SMG8 WIZ UBR5 CDC16 PRKDC PAK1IP1 MED23 HSPA8 RGPD5 | 3.11e-04 | 628 | 135 | 13 | int:SIRT6 |
| Interaction | SASH1 interactions | 3.49e-04 | 50 | 135 | 4 | int:SASH1 | |
| Interaction | MKS1 interactions | 3.50e-04 | 139 | 135 | 6 | int:MKS1 | |
| Interaction | H3C1 interactions | DSP ANP32B SMC5 SIRT1 CHUK ESCO2 BPTF WIZ CCNB3 WDR87 CDC16 PRKDC TAF2 HSPA8 NR1H4 KIF2C | 3.53e-04 | 901 | 135 | 16 | int:H3C1 |
| Interaction | COP1 interactions | 3.57e-04 | 326 | 135 | 9 | int:COP1 | |
| Interaction | MECP2 interactions | KDM5B RANBP2 COPA DSP ARHGAP35 SMC5 PRPF8 SIRT1 BPTF KIDINS220 NOP14 WIZ UPF2 EIF5B PDCD11 PRKDC PAK1IP1 MED23 HSPA6 HSPA8 | 3.63e-04 | 1287 | 135 | 20 | int:MECP2 |
| Interaction | FOXQ1 interactions | 3.78e-04 | 141 | 135 | 6 | int:FOXQ1 | |
| Interaction | HDAC1 interactions | KDM5B RANBP2 HIC1 WRN CKAP5 RFX3 BAHD1 SIRT1 ESCO2 BPTF IFRD1 WIZ UBR5 LMO7 SYNE2 DIAPH3 HSPA6 HSPA8 | 4.35e-04 | 1108 | 135 | 18 | int:HDAC1 |
| Interaction | UBE2I interactions | PRPSAP1 RGPD2 RANBP2 HIC1 LONRF1 PRPF8 SIRT1 PHC1 CHUK ZNF451 PSME3 PRKDC TNFRSF1A | 4.58e-04 | 654 | 135 | 13 | int:UBE2I |
| Interaction | SIRT1 interactions | 4.66e-04 | 412 | 135 | 10 | int:SIRT1 | |
| Interaction | ZNHIT2 interactions | 4.70e-04 | 96 | 135 | 5 | int:ZNHIT2 | |
| Interaction | NLRC5 interactions | 4.72e-04 | 23 | 135 | 3 | int:NLRC5 | |
| Interaction | FKBP5 interactions | PRPF8 CHUK SMG8 DNAAF10 DNAJC11 PDCD11 PSME3 PRKDC IKBKB HSPA8 | 4.83e-04 | 414 | 135 | 10 | int:FKBP5 |
| Interaction | XRCC6 interactions | KIAA0408 SWAP70 WRN ICE1 SMC5 PRPF8 BPTF WIZ PSME3 PRKDC MED23 RPA4 HSPA8 NR1H4 TBCD DNM2 | 4.88e-04 | 928 | 135 | 16 | int:XRCC6 |
| Interaction | DSN1 interactions | 4.93e-04 | 97 | 135 | 5 | int:DSN1 | |
| Interaction | NUP62 interactions | 5.15e-04 | 273 | 135 | 8 | int:NUP62 | |
| Interaction | PLEKHG7 interactions | 5.25e-04 | 150 | 135 | 6 | int:PLEKHG7 | |
| Interaction | RIT1 interactions | RANBP2 RGPD8 COPA IARS1 CKAP5 NOL10 ICE1 PRPF8 LONP1 IFRD1 XPO5 CDC16 DNAJC11 PDCD11 TAF2 PAK1IP1 METTL16 TBCD DNM2 | 5.55e-04 | 1230 | 135 | 19 | int:RIT1 |
| Interaction | TNFRSF1A interactions | 5.58e-04 | 211 | 135 | 7 | int:TNFRSF1A | |
| Interaction | WWTR1 interactions | 5.61e-04 | 422 | 135 | 10 | int:WWTR1 | |
| Interaction | FN1 interactions | ANP32B IARS1 CKAP5 PRPF8 TNFRSF11B PHC1 TGM2 KIDINS220 XPO5 CLIC2 EIF5B PRKDC HSPA8 DNM2 KIF2C | 5.67e-04 | 848 | 135 | 15 | int:FN1 |
| Interaction | G6PD interactions | 6.06e-04 | 214 | 135 | 7 | int:G6PD | |
| Interaction | TEDC1 interactions | 6.17e-04 | 58 | 135 | 4 | int:TEDC1 | |
| Interaction | EFTUD2 interactions | PRPSAP1 RANBP2 COPA DSP ANP32B IARS1 CKAP5 ARHGAP35 SMC5 PRPF8 LONP1 UBR5 XPO5 DNAAF10 SYNE2 EIF5B PSME3 PRKDC DIAPH3 HSPA6 HSPA8 | 6.42e-04 | 1449 | 135 | 21 | int:EFTUD2 |
| Interaction | CEBPA interactions | RANBP2 IARS1 CKAP5 NOL10 SIRT1 MED15 BPTF NOP14 WIZ UBR5 XPO5 EIF5B PDCD11 PSME3 PRKDC MED23 HSPA8 DNM2 KIF2C | 6.42e-04 | 1245 | 135 | 19 | int:CEBPA |
| Interaction | KIF20A interactions | RGPD4 RANBP2 RGPD8 COPA DSP LONRF1 IARS1 PRPF8 ESCO2 ACSL4 LONP1 KIDINS220 UBR5 LMO7 RGPD3 SYNE2 PRKDC | 6.72e-04 | 1052 | 135 | 17 | int:KIF20A |
| Cytoband | 11q22.2-q22.3 | 2.61e-05 | 3 | 136 | 2 | 11q22.2-q22.3 | |
| Cytoband | 6p24.2 | 3.86e-04 | 10 | 136 | 2 | 6p24.2 | |
| Cytoband | 15q14 | 4.24e-04 | 49 | 136 | 3 | 15q14 | |
| Cytoband | 2q13 | 1.11e-03 | 68 | 136 | 3 | 2q13 | |
| Cytoband | 2q12.3 | 1.15e-03 | 17 | 136 | 2 | 2q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p24 | 1.20e-03 | 70 | 136 | 3 | chr6p24 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.56e-08 | 115 | 83 | 8 | 769 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 8.70e-08 | 43 | 135 | 6 | MM3857 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM5B RANBP2 SWAP70 WRN CKAP5 SPG11 ARHGAP35 SMC5 ACSL4 BPTF IFRD1 KIDINS220 UPF2 UBR5 CDC16 ZNF451 SYNE2 IL7R | 4.39e-07 | 856 | 135 | 18 | M4500 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 7.11e-07 | 33 | 135 | 5 | MM477 | |
| Coexpression | SCIBETTA_KDM5B_TARGETS_DN | 3.41e-06 | 79 | 135 | 6 | M6787 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RANBP2 FOXN2 HIC1 ANP32B AOAH SPG11 ICE1 ARHGAP35 SMC5 PRPF8 CCND2 ACSL4 BPTF KIDINS220 UBR5 GLG1 CDC16 SECISBP2 HSPA8 IL7R TBCD | 2.56e-05 | 1492 | 135 | 21 | M40023 |
| Coexpression | GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN | 2.73e-05 | 168 | 135 | 7 | M2962 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | ANP32B IARS1 WRN CKAP5 PARVB TST ESCO2 TGM2 KATNBL1 NOP14 CDC16 ZNF451 DNAJC11 EIF5B PRKDC DIAPH3 PAK1IP1 HSPA8 KIF2C | 2.88e-05 | 1271 | 135 | 19 | M39197 |
| Coexpression | SENESE_HDAC2_TARGETS_UP | 3.11e-05 | 116 | 135 | 6 | M4113 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TREG_UP | 7.98e-05 | 199 | 135 | 7 | M3421 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 8.23e-05 | 200 | 135 | 7 | M387 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_DN | 8.23e-05 | 200 | 135 | 7 | M8261 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_DC_DN | 8.23e-05 | 200 | 135 | 7 | M8774 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN | 8.23e-05 | 200 | 135 | 7 | M6938 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RGPD4 PRPSAP1 RGPD2 RANBP2 RGPD8 COPA ANP32B SPG11 LONP1 SEPHS1 NOP14 CDC16 DNAJC11 RGPD3 EIF5B PSME3 TBCD | 9.79e-05 | 1158 | 135 | 17 | MM1338 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.15e-04 | 363 | 135 | 9 | M41103 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | RANBP2 ANP32B IARS1 CKAP5 SMC5 TTC3 RFX3 PHC1 ACSL4 EXOC5 IFRD1 NOP14 UBR5 EIF5B PRKDC KIF2C | 2.85e-07 | 532 | 135 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.49e-08 | 175 | 135 | 8 | f456d8d958b71f7a942b718605712593d9de1bfd | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-07 | 190 | 135 | 8 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-07 | 190 | 135 | 8 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.33e-07 | 192 | 135 | 8 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.38e-07 | 193 | 135 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.38e-07 | 193 | 135 | 8 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-07 | 194 | 135 | 8 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 195 | 135 | 8 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 195 | 135 | 8 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 195 | 135 | 8 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.48e-07 | 162 | 135 | 7 | ae292318d339305932457bb0e91430594f7a3dfa | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.69e-07 | 172 | 135 | 7 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-06 | 187 | 135 | 7 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.75e-06 | 188 | 135 | 7 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-06 | 189 | 135 | 7 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-06 | 189 | 135 | 7 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-06 | 192 | 135 | 7 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-06 | 193 | 135 | 7 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.16e-06 | 194 | 135 | 7 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.16e-06 | 194 | 135 | 7 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.24e-06 | 195 | 135 | 7 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-06 | 195 | 135 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.31e-06 | 196 | 135 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.39e-06 | 197 | 135 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-06 | 200 | 135 | 7 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.64e-06 | 200 | 135 | 7 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.64e-06 | 200 | 135 | 7 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.64e-06 | 200 | 135 | 7 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-06 | 200 | 135 | 7 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-06 | 200 | 135 | 7 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-06 | 200 | 135 | 7 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | facs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 149 | 135 | 6 | 23a1b95c12f2e3708dc003e13fab423e89821f11 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 149 | 135 | 6 | c53a3226adc8fd0eaaa842b6a96442287580cbe0 | |
| ToppCell | facs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 149 | 135 | 6 | bb18a18b891af85849b9658d774053f839c9a8e1 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 170 | 135 | 6 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 170 | 135 | 6 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-05 | 178 | 135 | 6 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 183 | 135 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 183 | 135 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 184 | 135 | 6 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-05 | 185 | 135 | 6 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.16e-05 | 185 | 135 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.22e-05 | 186 | 135 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-05 | 186 | 135 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-05 | 186 | 135 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-05 | 186 | 135 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 187 | 135 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-05 | 187 | 135 | 6 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 2.29e-05 | 187 | 135 | 6 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 2.36e-05 | 188 | 135 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.36e-05 | 188 | 135 | 6 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.43e-05 | 189 | 135 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 189 | 135 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 2.43e-05 | 189 | 135 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 2.43e-05 | 189 | 135 | 6 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-05 | 190 | 135 | 6 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-05 | 190 | 135 | 6 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.51e-05 | 190 | 135 | 6 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.51e-05 | 190 | 135 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.51e-05 | 190 | 135 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.58e-05 | 191 | 135 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-05 | 191 | 135 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 135 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 191 | 135 | 6 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.58e-05 | 191 | 135 | 6 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 135 | 6 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 2.58e-05 | 191 | 135 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-05 | 191 | 135 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-05 | 191 | 135 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 135 | 6 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.58e-05 | 191 | 135 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 135 | 6 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 135 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.58e-05 | 191 | 135 | 6 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 191 | 135 | 6 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.58e-05 | 191 | 135 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 2.58e-05 | 191 | 135 | 6 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-05 | 191 | 135 | 6 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 135 | 6 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 2.58e-05 | 191 | 135 | 6 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 2.66e-05 | 192 | 135 | 6 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 2.66e-05 | 192 | 135 | 6 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-05 | 192 | 135 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-05 | 192 | 135 | 6 | 348d39da3016dc6dbfa65d108e5def35aa7f19dd | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.74e-05 | 193 | 135 | 6 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 2.74e-05 | 193 | 135 | 6 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.74e-05 | 193 | 135 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| Disease | liver cancer (is_implicated_in) | 7.92e-07 | 5 | 128 | 3 | DOID:3571 (is_implicated_in) | |
| Disease | Autoimmune Diseases | 3.33e-05 | 42 | 128 | 4 | C0004364 | |
| Disease | breast cancer (is_implicated_in) | 5.08e-05 | 150 | 128 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | Pneumonia | 9.03e-05 | 54 | 128 | 4 | C0032285 | |
| Disease | Lobar Pneumonia | 9.03e-05 | 54 | 128 | 4 | C0032300 | |
| Disease | Pneumonitis | 9.03e-05 | 54 | 128 | 4 | C3714636 | |
| Disease | Experimental Lung Inflammation | 9.03e-05 | 54 | 128 | 4 | C0887898 | |
| Disease | Wallerian Degeneration | 1.11e-04 | 4 | 128 | 2 | C0043020 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.14e-04 | 195 | 128 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Cerebral ventriculomegaly | 3.87e-04 | 7 | 128 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 3.87e-04 | 7 | 128 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 3.87e-04 | 7 | 128 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 3.87e-04 | 7 | 128 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 3.87e-04 | 7 | 128 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 3.87e-04 | 7 | 128 | 2 | C0549423 | |
| Disease | muscular atrophy (implicated_via_orthology) | 3.87e-04 | 7 | 128 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | alcohol drinking | 4.34e-04 | 81 | 128 | 4 | EFO_0004329 | |
| Disease | Congenital Hydrocephalus | 5.14e-04 | 8 | 128 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 5.14e-04 | 8 | 128 | 2 | C2936786 | |
| Disease | response to 4'-epidoxorubicin, response to antineoplastic agent | 6.59e-04 | 9 | 128 | 2 | GO_0097327, GO_1902522 | |
| Disease | Hydrocephalus | 6.59e-04 | 9 | 128 | 2 | C0020255 | |
| Disease | Optic Atrophy | 8.21e-04 | 10 | 128 | 2 | C0029124 | |
| Disease | diffuse scleroderma (is_implicated_in) | 1.00e-03 | 11 | 128 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | Osteosarcoma | 1.12e-03 | 47 | 128 | 3 | C0029463 | |
| Disease | methionine sulfone measurement | 1.20e-03 | 12 | 128 | 2 | EFO_0800072 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.27e-03 | 49 | 128 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 1.41e-03 | 13 | 128 | 2 | C0750905 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 1.41e-03 | 13 | 128 | 2 | C0002514 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.41e-03 | 111 | 128 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.74e-03 | 291 | 128 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.09e-03 | 206 | 128 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | obsolete_red blood cell distribution width | PRPSAP1 SWAP70 ANP32B AOAH PARVB SMOC1 SLFN14 LONP1 CLIC2 SYNE2 PRKCE SLC30A10 HSPA8 DNM2 | 2.17e-03 | 1347 | 128 | 14 | EFO_0005192 |
| Disease | Atherosclerosis | 2.17e-03 | 59 | 128 | 3 | C0004153 | |
| Disease | Atherogenesis | 2.17e-03 | 59 | 128 | 3 | C1563937 | |
| Disease | lupus nephritis (is_marker_for) | 2.43e-03 | 17 | 128 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | ischemia (implicated_via_orthology) | 2.43e-03 | 17 | 128 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | migraine disorder, systolic blood pressure | 2.73e-03 | 18 | 128 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | disease free survival | 2.73e-03 | 18 | 128 | 2 | EFO_0000409 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.88e-03 | 222 | 128 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | osteoporosis (implicated_via_orthology) | 3.04e-03 | 19 | 128 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | Severe Combined Immunodeficiency | 3.37e-03 | 20 | 128 | 2 | C0085110 | |
| Disease | Non-alcoholic Fatty Liver Disease | 3.53e-03 | 70 | 128 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 3.53e-03 | 70 | 128 | 3 | C3241937 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.64e-03 | 144 | 128 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | left atrial function | 3.71e-03 | 21 | 128 | 2 | EFO_0004294 | |
| Disease | Lung Injury | 3.71e-03 | 21 | 128 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 3.71e-03 | 21 | 128 | 2 | C2350344 | |
| Disease | impotence (biomarker_via_orthology) | 4.07e-03 | 22 | 128 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | type 1 diabetes mellitus | 4.16e-03 | 242 | 128 | 5 | MONDO_0005147 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.20e-03 | 150 | 128 | 4 | EFO_0004611, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCKILDLPELIDNSK | 301 | Q9HAC7 | |
| RDLTPKKCQFLEKIL | 91 | Q8NDB2 | |
| DAPLCNLLLFKKVKA | 416 | O60488 | |
| TLKLVLKGQICKEIN | 191 | P11597 | |
| KFKQCKLLQELPDKI | 2441 | Q8IZF6 | |
| RNCLSLKDKPKVIIV | 241 | P49662 | |
| ESIVLECPDLKTKLL | 176 | P0C7M7 | |
| CSIEAKPLKSILQKE | 236 | Q5H913 | |
| KDISTLEPLKKLECL | 101 | Q92688 | |
| LEPLKKLECLKSLDL | 106 | Q92688 | |
| KEILPNLKCIKNDGL | 371 | Q9NSV4 | |
| DIGTLICKNKKPLIQ | 1351 | Q12830 | |
| LDLQEKPSIKKETLL | 896 | Q8WWL7 | |
| PTQKDLVLKIAELLC | 91 | P49792 | |
| PTQKDLVLKIAELLC | 91 | Q99666 | |
| PTQKDLVLKIAELLC | 91 | O14715 | |
| VQKCKNALKLPVLEV | 31 | Q2M385 | |
| LQEPLLDVLQKLCKI | 421 | Q96RI1 | |
| VLPDEICNLKKLETL | 76 | Q8N9N7 | |
| ICIPEEIKFLKKLQK | 166 | Q6ZNQ3 | |
| KLKETSPLTAEKLCI | 111 | P30279 | |
| SLPVLAKICQKIKLA | 161 | P28039 | |
| APKKKCIQIKDLILL | 1691 | Q8N7Z5 | |
| IEDISKVPLLEKCLQ | 346 | M0R2J8 | |
| PLQCLVKDSKLILTE | 491 | Q9NVH1 | |
| ENIPALKALLEKCKD | 16 | Q9ULH0 | |
| CVDLLPLVKSLLKSK | 216 | Q9H079 | |
| VVCKQKALELLPKVE | 616 | O14920 | |
| LQIPDLVALCKKRLK | 136 | Q14526 | |
| LLGCKQKIIDLLPKV | 611 | O15111 | |
| GLLKIKICEAVSLKP | 6 | Q02156 | |
| LVKRKPQACLKAVLA | 156 | Q8NAA5 | |
| KLQVQKILCDLLLPE | 316 | Q17RB8 | |
| IKTQPLEKLKQECLK | 6546 | Q5CZC0 | |
| LKLLREIEKAKPIKC | 56 | Q96MX6 | |
| KEQVEKIICNLKPAL | 1311 | Q9ULK4 | |
| PLKTLQKCEIALEKL | 581 | Q96RN5 | |
| CILPISLEKEKQKNR | 221 | Q6ZU52 | |
| LLCDLINKLKPGVIK | 96 | Q8WWI1 | |
| KKCSLAPLKEELRIQ | 251 | Q86W50 | |
| CLKKTKTENPLILID | 576 | P36776 | |
| LTCKKIDLTTIVKPE | 116 | P16871 | |
| KLLSPLQDVDIKICL | 1166 | Q9UGL1 | |
| PTEILCLKNLQILKL | 361 | Q05C16 | |
| LPKVNKELALKLIEE | 446 | Q9BSC4 | |
| LLTKCPILSLQDVVK | 576 | P78316 | |
| AIVKKQVVKLKEPCL | 411 | P50570 | |
| QVVKLKEPCLKCVDL | 416 | P50570 | |
| LLVILKLCPKKKSSS | 901 | Q9UPP2 | |
| PQLFSLNKEELKKVC | 656 | Q9H6S3 | |
| LQKLLEKLAGCKLNV | 121 | Q9HBI1 | |
| LCLVKINILVEDKLK | 101 | Q9Y5H0 | |
| PTQKDLVLKIAELLC | 91 | A6NKT7 | |
| LCPNIKKKVDVVICL | 766 | Q92896 | |
| SPKLSECLQKKKEII | 511 | O00471 | |
| EKELLESLPLSKLCN | 181 | Q13042 | |
| KNPKIIVACIETLRK | 136 | Q14008 | |
| QPLKKCVLTDLELII | 4276 | Q4G0P3 | |
| NITLKPKEVCKLEVI | 4476 | Q4G0P3 | |
| KLLLTIQLCPKTEFQ | 2086 | Q9Y2F5 | |
| LSLKDKPKVIIVQAC | 301 | P51878 | |
| KPCKETQIPLKLDNL | 466 | Q9HB55 | |
| KKLPKETLEQQKRIC | 1071 | P53621 | |
| LCLLPLKEKKKQVQT | 2441 | P15924 | |
| LKNKELCADNPILKK | 426 | Q9HC77 | |
| ELLEKDCNLKKVSIP | 111 | Q8WUF8 | |
| ETPGVKTLCNLKKLL | 31 | Q5T5N4 | |
| KPKACKVLLTRLENV | 66 | Q8TBE0 | |
| LLTICPINEVKKKLE | 251 | O00458 | |
| PKCLVLEEKLKIGLL | 261 | Q56NI9 | |
| LECEKPLPLKTALQK | 256 | P32314 | |
| LLDECILKQKSIIKL | 411 | Q8NA03 | |
| QKLQCPKIKTVDISL | 316 | Q14558 | |
| KCEKVQDLLLLDVAP | 386 | P17066 | |
| LPKCTDLKAKQLLLS | 5026 | Q8NDH2 | |
| QKKLLITLPELVECT | 171 | Q9NQM4 | |
| LQELPAPLLDDKCKK | 126 | Q96EB1 | |
| QKLNCLSPSLIAKDK | 486 | Q8IXS0 | |
| LAKLKLPPLSKCESL | 36 | Q15835 | |
| KEIDVISIPSKCLLL | 276 | Q99661 | |
| KCLLLVHEPKLKVDL | 286 | Q99661 | |
| LADCSLLPKLNIIKV | 181 | O15247 | |
| ELLRPKIKLCNSLEE | 981 | Q9HAU5 | |
| QKELEKVCNPIITKL | 596 | P11142 | |
| KVLPLLKTAIKDCPV | 236 | Q8ND04 | |
| PTEILTKLCKDNKLD | 1476 | Q2WGJ9 | |
| LKSLKNEILCPKLLN | 571 | Q8IW52 | |
| PTQKDLVLKIAELLC | 91 | Q7Z3J3 | |
| KEKLQKCLEPLEQKL | 151 | Q9HCM9 | |
| KVNPDLLKKEIENCI | 261 | P0C7P3 | |
| LLKKEIENCIEKLPT | 266 | P0C7P3 | |
| KQKLVKQLPLTSICL | 201 | Q17R31 | |
| LLPDDILSQIRKCKV | 2756 | Q8WXH0 | |
| KRLQELALALKKCKP | 56 | Q9BXJ8 | |
| IESRLPKAKLITLCK | 406 | P48380 | |
| PQKDLVLKIAELLCK | 91 | P0DJD1 | |
| LKPIQCFKLEKVSSL | 816 | Q5VVP1 | |
| RKLSECVPSLKKVQL | 561 | Q9H3E2 | |
| LCPKEVLTFILDLIK | 766 | Q6P1X5 | |
| INLLKSKKCPFIVAL | 741 | O60841 | |
| KPRKEETISQCLKKI | 16 | Q7Z4L9 | |
| CKVPQDVLQKLLESL | 31 | P49903 | |
| AVKLLQECKKIIVLT | 246 | Q96EB6 | |
| LKKLKCVIISPNCEK | 686 | Q96T21 | |
| DTLREILKKKSKPCL | 1266 | O95785 | |
| LILQANEELCPKKLL | 1061 | Q14191 | |
| KLRKKCNLVPTDEIT | 996 | P41252 | |
| LSCIKAKKLLETKPE | 361 | Q9NRY4 | |
| CKALAQPVCKLRKLI | 651 | Q7RTR0 | |
| KVKPEIRLLIEKCNT | 121 | P61289 | |
| LPKNVLKKFICISDL | 2106 | Q6P2Q9 | |
| GPDVKKLCILCQILK | 1636 | Q96JI7 | |
| DICLILLDVNPKFLK | 191 | P21980 | |
| SLLKLIVELEKKCGE | 186 | Q8N7C3 | |
| QLCLQTRILKPKEKI | 51 | Q8WWB5 | |
| LKKTLIESKLPVITC | 521 | Q14690 | |
| DLKEPLEQKDLLLLC | 386 | Q6XR72 | |
| NKDKVISLPELKGCL | 411 | Q9H4F8 | |
| KKLLISLCKDVPFQV | 301 | Q9Y4E5 | |
| CKPLLIDKLKFDIRL | 376 | Q8NHH1 | |
| IKACKPSDQILKLLS | 316 | O00300 | |
| LKCPTGTKSLEVLKI | 131 | Q13156 | |
| FKALLQLDPCENKIK | 111 | Q96C74 | |
| SENAKKAPDCLIKLL | 731 | Q5T4T6 | |
| VKLKKEISLLNGVCL | 31 | Q9UM01 | |
| CKLLNPSLQKVADKR | 1131 | Q9HAV4 | |
| PILKQKCSSLEKLRL | 751 | P53804 | |
| PEKCTKEQILELLVL | 76 | Q9GZW5 | |
| IKLGPALKICAKINV | 986 | P78364 | |
| LKQDKKVPPSLLCEI | 276 | Q9NWT1 | |
| KICLDLQAPLYKKII | 81 | P02776 | |
| AKCKIPALDLLIKLL | 121 | P78527 | |
| TLCVKKNLTKNPLLI | 96 | Q9UH65 | |
| PFAVKLLALCKKEIK | 1066 | Q9BTW9 | |
| KKVDLSQPLIATCRK | 236 | Q16762 | |
| KAKLVTELTNLIKIC | 746 | Q8IY18 | |
| CKVKLEEPINLSVKK | 796 | O15016 | |
| TKEALPIKCLEAVIL | 161 | Q7L8A9 | |
| KDICLPGKKINKERL | 196 | Q6NT04 | |
| KKSLECTKLCLPQIE | 186 | P19438 | |
| LFQEICPLLKKESKV | 1286 | Q6ZQQ6 | |
| CPLLKKESKVLLEDL | 1291 | Q6ZQQ6 | |
| KKLCIPEKTEILAVN | 736 | O95071 | |
| KAVPKVKLLCGADLL | 146 | Q9HAN9 |